Grassmann et al., analyzing 16,144 AMD cases and 17,832 controls, narrowed the risk haplotype to a 5,196 bp segment encompassing the ARMS2 promoter and first two exons, while excluding the HTRA1 promoter and ARMS2 3′ indel variant [22]. This evidence concerns the gene ARMS2 and age-related macular degeneration.